FDA Wants Zantac Pulled From Shelves & Consumers To Stop Using It
On Wednesday, the Food and Drug Administration announced that they are recommending that all prescription and over-the-counter (OTC) ranitidine drugs (Zantac) be removed from the market immediately. They are also advising consumers who are taking OTC ranitidine to "stop taking any tablets or liquid they currently have, dispose of them properly and not buy more; for those who wish to continue treating their condition, they should consider using other approved OTC products."
So, what's wrong with the product? The short answer is bad levels of impurities. The technical answer from the FDA is "the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S."